Nasdaq

Masimo (MASI) Boosts O3 Platform With Three New Indices

Masimo Corporation MASI announced that it developed three additional indices (delta cHb, delta HHb, and delta O2Hb) for O3 Regional Oximetry. These additions will enable clinicians to view the ...
Yahoo Finance

Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters

Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation ...
Nasdaq

Masimo O3® Regional Oximetry Receives FDA Clearance for Somatic Applications and Measurement of Relative Changes in Cerebral Hemoglobin

O3 Regional Oximetry provides regional or tissue hemoglobin oxygen saturation with a trending specification of 3% ARMS* (cerebral and somatic, all ages) and absolute accuracy specifications of 4% ARMS ...
Hosted on MSN

Masimo Shares Dip Despite FDA Clears Expanded Use of O3 Monitoring

Masimo MASI recently secured FDA 510(k) clearance for expanded indications of its O3 Regional Oximetry with delta hemoglobin parameters. These parameters track relative changes in hemoglobin levels, ...
The Globe and Mail

Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters

O3, available on Masimo’s Root ® patient monitoring and connectivity platform, uses near-infrared spectroscopy (NIRS) to monitor and display continuous regional oxygen saturation values (rSO2) in the ...